Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Optimal Control of all Modifiable Vascular Risk Factors Among Patients With Atherosclerotic Disease. A Real-Life Study.
Curr Probl Cardiol. 2023 Mar;48(3):101530. doi: 10.1016/j.cpcardiol.2022.101530. Epub 2022 Dec 5.
Curr Probl Cardiol. 2023.
PMID: 36481390
Review.
Location of recurrent cardiovascular events and anticardiolipin antibodies.
Galán-González J, Rico-Martín S, Calderón-García JF, Antón J, Ramírez-Moreno JM, Álvarez-Rodríguez LR, Sánchez Muñoz-Torrero JF; for FRENA Investigators.
Galán-González J, et al.
Eur J Clin Invest. 2021 Jul;51(7):e13533. doi: 10.1111/eci.13533. Epub 2021 Mar 11.
Eur J Clin Invest. 2021.
PMID: 33666941
Item in Clipboard
Sustained low-density lipoprotein-cholesterol <70 mg/dl is associated with improved cardiovascular outcomes in the clinical setting.
Sánchez-Bacaicoa C, Galán J, Guijarro C, Rico-Martín S, Monreal M, Calderón-García JF, Aguilar-Cortés E, Sánchez Muñoz-Torrero JF; for FRENA Investigators.
Sánchez-Bacaicoa C, et al.
Eur J Clin Invest. 2022 May;52(5):e13732. doi: 10.1111/eci.13732. Epub 2021 Dec 21.
Eur J Clin Invest. 2022.
PMID: 34908162
Item in Clipboard
Cite
Cite